James Brian Windsor
President and Chief Executive Officer · Rein Therapeutics, Inc.
- 2024
- May 13, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James Brian Windsor files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Voss Capital, LP - $128K in RNTX purchases and sales in the last 12 months
- Rickenbach Josef H. von - $50K in RNTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James Brian Windsor?
James Brian Windsor is a corporate insider, tracked as President and Chief Executive Officer of Rein Therapeutics, Inc. (RNTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James Brian Windsor last file a Form 4?
The most recent primary Form 4 on record is dated 13 May 2026, one of 3 filings going back to 2024.
Has James Brian Windsor been buying or selling stock?
Recorded transactions: 3 open-market purchases ($26K) and 0 open-market sales across all tracked filings.
